跳至主要内容
临床试验/NCT07219992
NCT07219992招募中不适用

Testing a Novel Parent-Based Treatment for Adolescent Anxiety Disorders

Yale University1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2025年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
108
试验地点
1
主要终点
Mean Pediatric Anxiety Rating Scale (PARS) score

研究概览

简要总结

This study aims to test the efficacy of a parent-only approach to treating anxiety disorders in adolescents: SPACE (Supportive Parenting for Anxious Childhood Emotions). The comparator is another parent-based approach, PES (Parent Education and Support). The study design is a randomized controlled trial with 2 treatment arms and 3 assessment points (pre, post, and follow-up) using questionnaire data and clinical interviews.

详细描述

The primary objective is to examine if SPACE is more efficacious than PES in reducing adolescent anxiety symptoms. The secondary objective is to examine if SPACE produces greater change than PES in improving family accommodation and family functioning.

SPACE and PES will be delivered over 12 sessions: Sessions 1-6 (once weekly), a mid-treatment assessment, Sessions 7-12 (once weekly), and a Post-treatment assessment.

Sessions can be attended in person or via Zoom.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

Adolescent participants and their parents will be enrolled.

入排标准

年龄范围
14 Years 至 17 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Meet criteria for a primary DSM-5 AD, including separation anxiety disorder, social anxiety disorder, generalized anxiety disorder, specific phobia, panic disorder, and agoraphobia (determined by the ADIS-C/P).
  • •Cease all other psychosocial treatment, upon consultation with the project staff and service provider.
  • •Not currently use any psychotropic medication, other than a stable dose (i.e., same dose for a minimum of 6 months prior to enrollment; no changes during course of the study) of a stimulant medication or selective serotonin reuptake inhibitor (SSRI).
  • •Have an eligible and willing participating parent (see parent exclusions below).

排除标准

  • •Adolescent:
  • •Meet criteria for any DSM-5 disorder more impairing than the most impairing AD (determined by the ADIS-C/P).
  • •Have any of the following disorders: autism spectrum disorder; intellectual disability; neurocognitive disorders; bipolar disorder; schizophrenia and other psychotic disorders; and alcohol and substance use disorders (determined by the Health History Form and ADIS-C/P).
  • •Report a suicide attempt in the last 3 months, or current suicide intent and plans (determined by the ASQ).
  • •Be a victim of past or present undisclosed abuse requiring investigation or ongoing supervision by the Department of Social Services.
  • •Not have sufficient proficiency with the English language to complete assessments.
  • •Have any of the following: intellectual disability; neurocognitive disorders; untreated bipolar disorder; untreated schizophrenia and other psychotic disorders; and untreated alcohol and substance use disorders (determined by the Health History Form).
  • •Not be living with the adolescent at least 50% of the time for at least one year prior to enrollment.
  • •Not have sufficient proficiency with the English language to complete assessments and treatment.

研究组 & 干预措施

Supportive Parenting for Anxious Childhood Emotions (SPACE)

Experimental

A parent-only approach to treating anxiety disorders in adolescents delivered over 12 sessions.

干预措施: Supportive Parenting for Anxious Childhood Emotions (SPACE) (Behavioral)

Parent Education and Support (PES)

Active Comparator

Parent-based approach comparator arm delivered over 12 sessions.

干预措施: Parent Educational Support (PES) (Behavioral)

结局指标

主要结局

Mean Pediatric Anxiety Rating Scale (PARS) score

时间窗: Week 1 and 14

This scale measures anxiety symptoms on 7 dimensions (e.g., avoidance, severity) from 0 ("minimal") to 5 ("extreme"). Total scores range from 0 - 35. Higher scores indicate greater anxiety severity.

Mean Screen for Child Anxiety Related Emotional Disorders (SCARED-C/P) score

时间窗: Week 1, 7 and 14

This scale assesses adolescent anxiety symptoms on a 3-point scale (0 "not true/hardly ever true" to 2 "very true/often true") with total score range = 0 - 82. Higher scores suggest greater anxiety symptoms.

Mean Child Anxiety Impact Scale (CAIS-C/P) score

时间窗: Week 1 and 14

This scale assesses adolescent anxiety that specifically captures impairment related to anxiety across important domains of functioning. Adolescents and parents rate items on a 4-point scale (0 "not at all" to 3 "very much"); total score range = 0 - 81. Higher scores suggest greater anxiety symptoms.

Clinical Global Impression Scale - Severity (CGI-S) and Improvement (CGI-I) scales score

时间窗: Week 1 and 14

This measure will be used to assess overall severity (CGI-S) and improvement (CGI-I) in adolescent anxiety. Total score range for each is 1-7. (Scores of 1 ("very much improved/normal") or 2 ("much improved/borderline ill") indicate a positive treatment response; all other responses are considered negative responses. Higher scores indicate worse outcome.

次要结局

  • Mean Family Accommodation Scale - Anxiety (FASA-C/P) score(Week 1, 8 and 14)
  • Mean Family Assessment Device - General Functioning Scale (FAD-GF) score(Week 1 and 14)
  • Mean Parent Problem Checklist scale score(Week 1 and 14)
  • Mean Parent Behavior Inventory - Child and Parent Report (CRPBI/PRPBI) scale score(Week 1 and 14)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验